In the case of prescription drugs, we know that 20%-30% of patients report cost-related nonadherence
— G. Caleb Alexander, MD, bioethicist at the University of Chicago’s MacLean Center for Clinical Medical Ethics. From The One Subject That Doctors and Patients Still Avoid: Introduction
